Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

257 ta ish

Ish: Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

  1. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

    Bertram Pitt, Faı̈ez Zannad, Willem J. Remme +5

    Maqola19993 iqtibos
    ABI

  2. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials

    Michael Böhm, Helmut Schumacher, Koon Teo +10

    Sharh maqola20173 iqtibos
    ABI

  3. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

    Sadiya S. Khan, Hongyan Ning, John T. Wilkins +5

    Maqola20183 iqtibos
    ABI

  4. Diagnosis and treatment of arterial hypertension [Guidelines]

    И Е Чазова, Yu. V. Zhernakova

    Maqola20193 iqtibos
    ABI

  5. In-Hospital Outcomes of Percutaneous Coronary Interventions in Extremely Obese and Normal-Weight Patients

    Saeed Payvar, Sunghee Kim, Sunil V. Rao +4

    Maqola20132 iqtibos
    ABI

  6. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes

    Hussam Abuissa, Philip G. Jones, Steven P. Marso +1

    Sharh maqola20052 iqtibos
    ABI

  7. Combining Body Mass Index With Measures of Central Obesity in the Assessment of Mortality in Subjects With Coronary Disease

    Thais Coutinho, Kashish Goel, Daniel Correa de +16

    Maqola20132 iqtibos
    ABI

  8. Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation

    Rajeev K. Pathak, Melissa E. Middeldorp, Dennis H. Lau +10

    Maqola20142 iqtibos
    ABI

  9. Is There an Obesity Paradox After Percutaneous Coronary Intervention in the Contemporary Era?

    T. Lancefield, David Clark, Nick Andrianopoulos +9

    Maqola20102 iqtibos
    ABI

  10. Risk of Myocardial Infarction and Heart Failure Among Metabolically Healthy But Obese Individuals

    Bjørn Mørkedal, Lars J. Vatten, Pål Romundstad +2

    Maqola20132 iqtibos
    ABI

  11. Effect of uncomplicated obesity on QT interval in young men

    Erol Arslan, Ömer Yiğiner, İrfan Yavaşoğlu +3

    Maqola20102 iqtibos
    ABI

  12. Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation

    Christopher X. Wong, Thomas Sullivan, Michelle T. Sun +9

    Maqola20152 iqtibos
    ABI

  13. Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy

    Tetsuo Konno, Kenshi Hayashi, Noboru Fujino +10

    Maqola20152 iqtibos
    ABI

  14. Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

    John J McMurray, John J.V. McMurray, Steven M Haffner +51

    Maqola20102 iqtibos
    ABI

  15. Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome

    Sebastien X Joncas, Paul Poirier, Jean‐Luc Ardilouze +3

    Maqola20132 iqtibos
    ABI

  16. Effect of Obesity and Overweight on Left Ventricular Diastolic Function

    C Allison Russo, Zhezhen Jin, Shunichi Homma +4

    Maqola20112 iqtibos
    ABI

  17. Patients with Metabolic Syndrome Have Prolonged Corrected QT Interval (QTc)

    Weiju Li, Yongyi Bai, Kai Sun +7

    Maqola20092 iqtibos
    ABI

  18. Pericardial fat is associated with ventricular tachyarrhythmia and mortality in patients with systolic heart failure

    Cho‐Kai Wu, Hao‐Yuan Tsai, Mao‐Yuan Su +5

    Maqola20152 iqtibos
    ABI

  19. The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation

    Usha B. Tedrow, David Conen, Paul M. Ridker +5

    Maqola20102 iqtibos
    ABI

  20. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial

    Sverre E. Kjeldsen, Eivind Berge, Sripal Bangalore +8

    Maqola20152 iqtibos
    ABI

  21. A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide

    Matthew R. Weir, Willa A. Hsueh, Shawna D. Nesbitt +7

    Maqola20112 iqtibos
    ABI

  22. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

    Renate B. Schnabel, Xiaoyan Yin, Philimon Gona +12

    Maqola20152 iqtibos
    ABI

  23. Metabolic syndrome update

    Scott M. Grundy

    Sharh maqola20152 iqtibos
    ABI

  24. Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation

    Hany S. Abed, Gary Wittert, Darryl P. Leong +10

    Maqola20132 iqtibos
    ABI

  25. Relief of Cardiorespiratory Symptoms and Increased Physical Activity After Surgically Induced Weight Loss

    Kristjan Karason, Anna Karin Lindroos, Kaj Stenlöf +1

    Maqola20002 iqtibos
    ABI